Evidence map›Paper›PMID 35995824›Full record

ArticleScientific reports2022

Correlations between APOE4 allele and regional amyloid and tau burdens in cognitively normal older individuals.

Yun Jeong Hong, Chan-Mi Kim, Jae Hong Lee, Jorge Sepulcre

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Effects of APOE4 on omega-3 brain metabolism across the lifespan.Trends in endocrinology and metabolism: TEM · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Yun Jeong Hong *Department of Neurology, Uijeongbu St. Mary's Hospital, Catholic University of Korea, Seoul, Korea.
Chan-Mi Kim *Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Jae Hong LeeDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jorge SepulcreGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. sepulcre@nmr.mgh.harvard.edu.
Athinoula A. Martinos Center for Biomedical Imaging · USHarvard University · USThe Catholic University of Korea Uijeongbu St. Mary's Hospital · KRUniversity of Ulsan · KR

Funding

Genetic Profiles of the Spatiotemporal Causality of Tau and Amyloid in the Elderly BrainR01AG061445 · NIA · YALE UNIVERSITY · PI SEPULCRE, JORGE · 2019 to 2023
$1.9M
Sensory and Motor Streams in Preclinical and Clinical Stages of Alzheimer's DiseaseR01AG061811 · NIA · YALE UNIVERSITY · PI SEPULCRE, JORGE · 2019 to 2023
$1.7M
National Institutes of Health (NIH) R01AG061811NIA NIH HHS R01 AG061445NIA NIH HHS R01 AG061811
6 · The paper itself

Abstract

The correlations between apolipoprotein epsilon 4 (APOE4) status and regional amyloid, tau, and cortical thickness in cognitively normal elderly are not fully understood. Our cross-sectional study aimed to compare regional amyloid/tau burden, and cortical thickness according to APOE4 carrier status and assess correlations between APOE4 and Alzheimer's disease (AD)-related biomarker burdens. We analyzed 185 cognitively normal participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Participants aged 55-90 with normal cognitive function were divided into amyloid ß-positive (Aß+) APOE4 carriers (group 1, n = 27), Aß+ APOE4 non-carriers (group 2, n = 29), and Aß- normal controls (group 0, n = 129). We compared amyloid depositions, tau depositions, and cortical thickness among the three groups and assessed correlations between APOE4 existence and imaging biomarkers adjusted for age and sex. The participants in group 2 were older than those in the other groups. The regional amyloid/tau standardized uptake value ratios (SUVRs) did not differ between groups 1 and 2, but the amyloid/tau SUVRs in most regions were numerically higher after adjusting for age difference. APOE4 allele had robust correlations with increased amyloid burden in the fronto-temporo-parietal cortical areas after adjustment for age and sex, but it had weaker and mixed correlations with the regional tau burden and did not have significant correlation with cortical thickness. We identified that the presence of APOE4 allele might be more highly associated with amyloid deposition than with other AD-related biomarkers such as tau or cortical thickness in cognitively normal elderly.

Indexed as

Alzheimer DiseaseAmyloidosisApolipoprotein E4Cognitive DysfunctionAgedAllelesAmyloidAmyloid beta-PeptidesAmyloidogenic ProteinsApolipoproteins EBiomarkersBrainCross-Sectional StudiesHumansPositron-Emission Tomographytau ProteinsAmyloidAmyloid beta-PeptidesAmyloidogenic ProteinsApoE protein, humanApolipoprotein E4Apolipoproteins EBiomarkerstau Proteins

Identifiers

PMID35995824
PMCPMC9395408
OpenAlexW4292608035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.